Zobrazeno 1 - 3
of 3
pro vyhledávání: '"on behalf of the MSVACCS Investigators"'
Autor:
Lisa Grech, Alastair Kwok, Mike Nguyen, Antony Winkel, Ernest Butler, Michelle Allan, Nathan Bain, Eva Segelov, on behalf of the MSVACCS Investigators
Publikováno v:
Vaccines, Vol 11, Iss 2, p 410 (2023)
Background: People with multiple sclerosis (MS) are susceptible to severe COVID-19 outcomes. They were included as a priority group for the Australian COVID-19 vaccine roll-out in early 2021. However, vaccine hesitancy remains a complex barrier to va
Externí odkaz:
https://doaj.org/article/d29a72841ba74128add989fb327b0107
Autor:
Grech, Lisa, Kwok, Alastair, Nguyen, Mike, Winkel, Antony, Butler, Ernest, Allan, Michelle, Bain, Nathan, Segelov, Eva, Investigators, on behalf of the MSVACCS Investigators on behalf of the MSVACCS
Publikováno v:
Grech, Lisa; Kwok, Alastair; Nguyen, Mike; Winkel, Antony; Butler, Ernest; Allan, Michelle; Bain, Nathan; Segelov, Eva (2023). COVID-19 Vaccine Status, Intent, Hesitancy, and Disease-Related Beliefs in People with Multiple Sclerosis. Vaccines, 11(2) MDPI 10.3390/vaccines11020410
Vaccines
Volume 11
Issue 2
Pages: 410
Vaccines
Volume 11
Issue 2
Pages: 410
Background: People with multiple sclerosis (MS) are susceptible to severe COVID-19 outcomes. They were included as a priority group for the Australian COVID-19 vaccine roll-out in early 2021. However, vaccine hesitancy remains a complex barrier to va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b54a4cf61f3e7569bf0741903286fb2
Autor:
Grech L; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia., Kwok A; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.; Department of Oncology, Monash Health, Clayton, VIC 3168, Australia., Nguyen M; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.; Department of Oncology, Monash Health, Clayton, VIC 3168, Australia., Winkel A; Department of Neurology, Sunshine Coast Hospital and Health Service, Birtinya, QLD 4575, Australia.; School of Medicine, Griffith University, Birtinya, QLD 4575, Australia., Butler E; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.; Monash Neurology, Monash Health, Clayton, VIC 3168, Australia., Allan M; Monash Neurology, Monash Health, Clayton, VIC 3168, Australia., Bain N; Department of Oncology, Monash Health, Clayton, VIC 3168, Australia., Segelov E; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.; Department of Oncology, Monash Health, Clayton, VIC 3168, Australia.; Department of Clinical Research, Faculty of Medicine, University of Bern, 3012 Bern, Switzerland., On Behalf Of The Msvaccs Investigators
Publikováno v:
Vaccines [Vaccines (Basel)] 2023 Feb 10; Vol. 11 (2). Date of Electronic Publication: 2023 Feb 10.